Hirn Carole, Kanemaru Yuki, Stedeford Todd, Paschke Thilo, Baskerville-Abraham Irene
Scientific and Regulatory Affairs, JT International SA, Geneva, Switzerland.
Toxicol Rep. 2020 Nov 2;7:1502-1513. doi: 10.1016/j.toxrep.2020.10.019. eCollection 2020.
Novel tobacco products that heat rather than burn tobacco (heated tobacco products or HTPs) have been shown to produce lower levels of harmful and potentially harmful constituents than conventional combusted cigarettes. The present study uses a quantitative risk assessment approach to compare non-cancer and cancer risk estimates for emissions generated by an HTP with smoke from a reference cigarette (3R4F). Fifty-four analytes were evaluated from the HTP aerosol and the 3R4F cigarette smoke. Emissions were generated using the ISO and the Health Canada Intense smoking regimes. The measured values were extrapolated to define a conservative exposure assumption for per day use and lifetime use based on an estimated maximum usage level of 400 puffs per day , approximately 8 HTP tobacco capsules or 40 combustible cigarettes. Non-cancer and cancer risk estimates were calculated using these exposure assumptions for individual and per health outcome domains based on toxicological reference values derived by regulatory and/or public health agencies. The results of this assessment showed a reduction of non-cancer and cancer risk estimates by more than 90 % for the HTP the 3R4F cigarette, regardless of the smoking regime.
与传统燃烧香烟相比,新型烟草产品加热而非燃烧烟草(加热烟草产品或HTP)已被证明产生的有害和潜在有害成分水平更低。本研究采用定量风险评估方法,比较HTP产生的排放物与对照香烟(3R4F)烟雾的非癌症和癌症风险估计值。对HTP气溶胶和3R4F香烟烟雾中的54种分析物进行了评估。使用ISO和加拿大卫生部强烈吸烟模式产生排放物。根据每天估计最大使用量400口(约8个HTP烟草胶囊或40支可燃香烟),将测量值外推以确定每天使用和终身使用的保守暴露假设。基于监管和/或公共卫生机构得出的毒理学参考值,使用这些暴露假设针对个体和每个健康结果领域计算非癌症和癌症风险估计值。该评估结果显示,无论吸烟模式如何,HTP相对于3R4F香烟的非癌症和癌症风险估计值均降低了90%以上。